Glenview Capital Management - Q2 2020 holdings

$3.63 Billion is the total value of Glenview Capital Management's 44 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 50.0% .

 Value Shares↓ Weighting
THC BuyTENET HEALTHCARE CORP$357,878,000
+25.9%
19,761,353
+0.1%
9.87%
+27.7%
TAK SellTAKEDA PHARMACEUTICAL CO LTDsponsored ads$290,382,000
-4.1%
16,195,310
-18.8%
8.00%
-2.8%
BHC SellBAUSCH HEALTH COS INC$286,131,000
+11.1%
15,644,128
-5.9%
7.89%
+12.7%
CI SellCIGNA CORP NEW$244,273,000
-6.1%
1,301,750
-11.3%
6.73%
-4.8%
HCA SellHCA HEALTHCARE INC$209,379,000
-17.1%
2,157,209
-23.3%
5.77%
-16.0%
DXC BuyDXC TECHNOLOGY CO$197,802,000
+38.0%
11,988,030
+9.1%
5.45%
+39.9%
MCK SellMCKESSON CORP$186,974,000
-15.8%
1,218,704
-25.8%
5.16%
-14.6%
VIAC SellVIACOMCBS INCcl b$134,248,000
+3.2%
5,756,784
-38.0%
3.70%
+4.7%
NUAN SellNUANCE COMMUNICATIONS INC$127,591,000
+24.4%
5,042,131
-17.5%
3.52%
+26.2%
LH NewLABORATORY CORP AMER HLDGS$121,932,000734,044
+100.0%
3.36%
FMC SellF M C CORP$114,276,000
-28.0%
1,147,119
-41.0%
3.15%
-27.0%
HOLX SellHOLOGIC INC$110,337,000
-19.6%
1,935,735
-50.5%
3.04%
-18.5%
MTOR SellMERITOR INC$107,939,000
+13.0%
5,451,480
-24.4%
2.98%
+14.6%
ABC BuyAMERISOURCEBERGEN CORP$96,251,000
+47.4%
955,159
+29.4%
2.65%
+49.4%
IQV SellIQVIA HLDGS INC$78,212,000
-57.7%
551,258
-67.8%
2.16%
-57.1%
BSX SellBOSTON SCIENTIFIC CORP$74,187,000
-4.8%
2,113,001
-11.5%
2.04%
-3.4%
CTVA BuyCORTEVA INC$67,450,000
+102.6%
2,517,740
+77.7%
1.86%
+105.5%
HUM SellHUMANA INC$66,434,000
-37.0%
171,332
-49.0%
1.83%
-36.1%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$62,994,000
+79.4%
678,152
+91.4%
1.74%
+82.1%
DVA NewDAVITA INC$62,321,000787,483
+100.0%
1.72%
DGX NewQUEST DIAGNOSTICS INC$62,229,000546,061
+100.0%
1.72%
MAR NewMARRIOTT INTL INC NEWcl a$61,888,000721,889
+100.0%
1.71%
MOH BuyMOLINA HEALTHCARE INC$59,093,000
+51.8%
332,019
+19.1%
1.63%
+53.8%
CAR SellAVIS BUDGET GROUP$52,084,000
+12.0%
2,275,409
-32.0%
1.44%
+13.6%
URI SellUNITED RENTALS INC$48,187,000
+18.4%
323,316
-18.3%
1.33%
+20.0%
BKD SellBROOKDALE SR LIVING INC$39,343,000
-28.5%
13,336,554
-24.4%
1.08%
-27.5%
ESI SellELEMENT SOLUTIONS INC$34,652,000
+2.4%
3,193,768
-21.1%
0.96%
+3.8%
UNH SellUNITEDHEALTH GROUP INC$32,700,000
-53.5%
110,866
-60.6%
0.90%
-52.8%
ENDP SellENDO INTL PLC$32,403,000
-9.5%
9,446,971
-2.4%
0.89%
-8.3%
TMO NewTHERMO FISHER SCIENTIFIC INC$29,551,00081,555
+100.0%
0.82%
EBAY SellEBAY INC.$29,066,000
+15.6%
554,162
-33.7%
0.80%
+17.3%
MIK BuyMICHAELS COS INC$24,751,000
+491.7%
3,500,850
+35.6%
0.68%
+498.2%
EXPE NewEXPEDIA GROUP INC$20,965,000255,049
+100.0%
0.58%
MYGN BuyMYRIAD GENETICS INC$20,534,000
-6.8%
1,810,727
+17.6%
0.57%
-5.5%
FISV SellFISERV INC$16,420,000
-79.4%
168,200
-80.0%
0.45%
-79.1%
LYFT NewLYFT INC$12,828,000388,614
+100.0%
0.35%
CAR NewAVIS BUDGET GROUPcall$11,445,000500,000
+100.0%
0.32%
PACB SellPACIFIC BIOSCIENCES CALIF IN$10,878,000
+10.1%
3,153,150
-2.3%
0.30%
+11.5%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$8,797,000120,332
+100.0%
0.24%
HST NewHOST HOTELS & RESORTS INC$8,002,000741,628
+100.0%
0.22%
BAX SellBAXTER INTL INC$6,607,000
-83.1%
76,738
-84.1%
0.18%
-82.9%
GOOGL SellALPHABET INCcap stk cl a$5,452,000
-86.8%
3,845
-89.2%
0.15%
-86.6%
PRAH NewPRA HEALTH SCIENCES INC$2,197,00022,579
+100.0%
0.06%
EW SellEDWARDS LIFESCIENCES CORP$233,000
-92.7%
3,375
-80.0%
0.01%
-93.1%
LOW ExitLOWES COS INC$0-29,630
-100.0%
-0.07%
MDT ExitMEDTRONIC PLC$0-39,671
-100.0%
-0.10%
ABT ExitABBOTT LABS$0-46,752
-100.0%
-0.10%
CHRS ExitCOHERUS BIOSCIENCES INC$0-426,738
-100.0%
-0.19%
ISRG ExitINTUITIVE SURGICAL INC$0-14,779
-100.0%
-0.20%
NSP ExitINSPERITY INC$0-440,733
-100.0%
-0.45%
ExitNUANCE COMMUNICATIONS INCdbcv 1.000%12/1$0-20,000,000
-100.0%
-0.52%
MSFT ExitMICROSOFT CORP$0-209,477
-100.0%
-0.90%
GPN ExitGLOBAL PMTS INC$0-254,865
-100.0%
-1.00%
CNC ExitCENTENE CORP DEL$0-941,457
-100.0%
-1.52%
FLEX ExitFLEX LTDord$0-11,744,352
-100.0%
-2.67%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings